Luis Vega Batista v. HHS - MMR, idiopathic thrombocytopenic purpura (ITP) (2026)
Case summary [AI summaries can sometimes make mistakes]
On October 26, 2023, Luis Vega Batista filed a petition alleging that a measles-mumps-rubella (MMR) vaccine administered on October 30, 2020 caused idiopathic thrombocytopenic purpura (ITP). Respondent filed a Rule 4(c) report on March 6, 2026 agreeing that the claim was appropriate for compensation as a Table ITP injury.
Respondent agreed that Mr. Vega Batista's ITP began within the Table timeframe of 7 to 42 days after MMR vaccination, that he demonstrated clinical manifestations of ITP, that his serum platelet count was less than 50,000, and that there was no applicable exclusion.
Special Master Mindy Michaels Roth, through Special Master Young's captioned ruling, granted entitlement on March 10, 2026. The decision resolved entitlement only.
Damages had not yet been awarded in the public record reviewed for this update.
Theory of causation
MMR vaccine on October 30, 2020, causing Table ITP; ENTITLEMENT GRANTED/PENDING DAMAGES. Respondent conceded onset within the 7-42 day Table window, clinical manifestations of ITP, platelet count under 50,000, and no exclusion. No award yet in reviewed record. Special Master Young, petition filed October 26, 2023; entitlement ruling March 10, 2026. Attorney: Jeffrey S. Pop, Jeffrey S. Pop & Associates, Beverly Hills CA.
Source PDFs
USCOURTS-cofc-1_23-vv-01890